Tirzepatide Bigger Results, Bigger Buzz Why it's popular: Tirzepatide (Mounjaro/Zepbound) is a dual GLP-1/GIP agonist that outperformed semaglutide head-to-head, reaching about 20.9% weight loss in SURMOUNT-1 ( Jastreboff et al., NEJM 2022 )
Is it cellular longevity and direct liver support
[Gut-First Approach to Wellness] Supports digestive comfort, regularity, and nutrient absorption with a synergistic blend of probiotics, plant-based prebiotics, and glp1 for weight loss
All prescription medications carry potential risks
For patients managing training loads along the Concord River trails, IV glutathione is often paired with a recovery focused IV drip to support both muscle repair and mental clarity for the work week ahead
Patients with high-sensitivity GLP1R variants typically feel effects within 24-48 hours, while others may need 5-7 days, helping set accurate expectations